Grifols, S.A. American Depositary Shares GRFS
i
Market datapartial · fetched 2026-11-04T02:59:31.529Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T21:29:03.89244131Z
FundamentalsAlpha Vantage · unavailable
Grifols, S.A. American Depositary Shares options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 6.84 | 162.6% | 25.5% | |||
| 25Δ | 15.15 | 270.9% | 82.2% | 8.05 | 57.4% | 9.0% |
| 30Δ | 10.69 | 143.6% | 28.9% | 8.22 | 64.6% | 8.5% |
| 35Δ | 10.21 | 142.4% | 24.5% | 8.38 | 71.8% | 8.1% |
| 40Δ | 8.55 | 79.1% | 7.6% | |||
| 45Δ | 8.90 | 62.3% | 7.4% | 8.72 | 86.3% | 7.2% |
| 50Δ | 8.76 | 60.6% | 6.5% | 8.89 | 93.5% | 6.8% |
| 55Δ | 8.62 | 58.8% | 5.6% | 9.08 | 97.5% | 6.1% |
| 60Δ | 8.49 | 57.0% | 4.7% | 9.31 | 95.1% | 5.2% |
| 65Δ | 8.35 | 55.2% | 3.9% | 9.55 | 92.8% | 4.3% |
| 70Δ | 8.22 | 53.5% | 3.0% | 9.78 | 90.5% | 3.3% |
| 75Δ | 8.08 | 51.7% | 2.1% | |||
| 80Δ | 7.44 | 82.8% | 1.6% | 11.52 | 133.5% | 2.5% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 6.84
- IV
- 162.6%
- B/E move
- 25.5%
25Δ
- Pseudo strike
- 15.15
- IV
- 270.9%
- B/E move
- 82.2%
- Pseudo strike
- 8.05
- IV
- 57.4%
- B/E move
- 9.0%
30Δ
- Pseudo strike
- 10.69
- IV
- 143.6%
- B/E move
- 28.9%
- Pseudo strike
- 8.22
- IV
- 64.6%
- B/E move
- 8.5%
35Δ
- Pseudo strike
- 10.21
- IV
- 142.4%
- B/E move
- 24.5%
- Pseudo strike
- 8.38
- IV
- 71.8%
- B/E move
- 8.1%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 8.55
- IV
- 79.1%
- B/E move
- 7.6%
45Δ
- Pseudo strike
- 8.90
- IV
- 62.3%
- B/E move
- 7.4%
- Pseudo strike
- 8.72
- IV
- 86.3%
- B/E move
- 7.2%
50Δ
- Pseudo strike
- 8.76
- IV
- 60.6%
- B/E move
- 6.5%
- Pseudo strike
- 8.89
- IV
- 93.5%
- B/E move
- 6.8%
55Δ
- Pseudo strike
- 8.62
- IV
- 58.8%
- B/E move
- 5.6%
- Pseudo strike
- 9.08
- IV
- 97.5%
- B/E move
- 6.1%
60Δ
- Pseudo strike
- 8.49
- IV
- 57.0%
- B/E move
- 4.7%
- Pseudo strike
- 9.31
- IV
- 95.1%
- B/E move
- 5.2%
65Δ
- Pseudo strike
- 8.35
- IV
- 55.2%
- B/E move
- 3.9%
- Pseudo strike
- 9.55
- IV
- 92.8%
- B/E move
- 4.3%
70Δ
- Pseudo strike
- 8.22
- IV
- 53.5%
- B/E move
- 3.0%
- Pseudo strike
- 9.78
- IV
- 90.5%
- B/E move
- 3.3%
75Δ
- Pseudo strike
- 8.08
- IV
- 51.7%
- B/E move
- 2.1%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 7.44
- IV
- 82.8%
- B/E move
- 1.6%
- Pseudo strike
- 11.52
- IV
- 133.5%
- B/E move
- 2.5%
Options history
Table
| Date | IV (%) |
|---|---|
| 40.78% | |
| 53.01% | |
| 51.15% | |
| 67.96% | |
| 49.40% | |
| 55.22% | |
| 59.73% | |
| 61.89% | |
| 58.06% | |
| 53.22% | |
| 73.53% | |
| 47.18% | |
| 61.54% | |
| 42.85% | |
| 54.77% | |
| 44.86% | |
| 52.85% | |
| 74.34% | |
| 98.91% | |
| 99.86% | |
| 162.48% | |
| 54.77% | |
| 67.18% | |
| 66.88% | |
| 64.00% | |
| 65.77% | |
| 66.99% | |
| 113.31% | |
| 123.66% | |
| 54.76% | |
| 55.64% | |
| 62.47% | |
| 59.62% | |
| 51.45% | |
| 56.33% | |
| 49.61% | |
| 43.95% | |
| 55.91% |
Drug Manufacturers - General
GSK
GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines, over-the-counter drugs and health-related…
More →JNJ
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a…
More →LLY
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125…
More →MRK
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in…
More →NVO
Description unavailable
More →NVS
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
More →